{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:18:42Z","timestamp":1790774322815,"version":"4.1.0"},"reference-count":43,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fondazione Cassa di Risparmio di Torino"},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry for Education"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>MicroRNA-191-5p regulates key cellular processes involved in the pathogenesis of diabetic complications such as angiogenesis, extracellular matrix deposition, and inflammation. However, no data on circulating microRNA-191-5p in the chronic complications of diabetes are available.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess whether serum levels of microRNA-191-5p were associated with micro- and macrovascular disease in a large cohort of subjects with type 1 diabetes mellitus (DM1) from the EURODIAB Prospective Complication Study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Setting<\/jats:title><jats:p>Levels of microRNA-191-5p were measured by quantitative PCR in 420 patients with DM1 recruited as part of the cross-sectional analysis of the EURODIAB Prospective Complication Study. Cases (n = 277) were subjects with nephropathy and\/or retinopathy and\/or cardiovascular disease (CVD). Controls (n = 143) were patients without complications. Logistic regression analysis was performed to evaluate the potential independent association of microRNA-191-5p levels with chronic complications of diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Levels of microRNA-191-5p were significantly reduced (P &amp;lt; .001) in cases compared with controls even after adjustment for age, sex, and diabetes duration. Logistic regression analysis revealed that microRNA-191-5p was negatively associated with a 58% reduced odds ratio (OR) of chronic diabetes complications, specifically CVD, micro-macroalbuminuria, and retinopathy (OR, 0.42; 95% CI, 0.23-0.77), independent of age, sex, physical activity, educational levels, diabetes duration, glycated hemoglobin, total insulin dose, hypertension, smoking, total cholesterol, albumin excretion rate, estimated glomerular filtration rate, serum vascular cell adhesion molecule-1, and tumor necrosis factor-\u03b1. Analyses performed separately for each complication demonstrated a significant independent association with albuminuria (OR, 0.36; 95% CI, (0.18-0.75) and CVD (OR, 0.34; 95% CI, 0.16-0.70).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In DM1 subjects, microRNA-191-5p is inversely associated with vascular chronic complications of diabetes.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgad468","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T18:16:08Z","timestamp":1691518568000},"page":"e163-e174","source":"Crossref","is-referenced-by-count":5,"title":["Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: The EURODIAB Prospective Complications Study"],"prefix":"10.1210","volume":"109","author":[{"given":"Stefania","family":"Bellini","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, University of Turin , 10126 Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Guarrera","sequence":"additional","affiliation":[{"name":"Italian Institute for Genomic Medicine, IIGM , 10060 Candiolo , Italy"},{"name":"Candiolo Cancer Institute, FPO-IRCCS , 10060 Candiolo , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Matullo","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin , 10126 Turin , Italy"},{"name":"Medical Genetics Unit, AOU Citt\u00e0 della Salute e della Scienza , 10126 Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"Schalkwijk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University , 6221 Maastricht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen D","family":"Stehouwer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University , 6221 Maastricht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nish","family":"Chaturvedi","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Science, University College London , London WC1E 6BT , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabita S","family":"Soedamah-Muthu","sequence":"additional","affiliation":[{"name":"Center of Research on Psychology in Somatic Diseases (CORPS), Department of Medical and Clinical Psychology, Tilburg University , 5048 Tilburg , the Netherland"},{"name":"Institute for Food, Nutrition and Health , University of Reading Reading RG6 6UR , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9319-5123","authenticated-orcid":false,"given":"Federica","family":"Barutta","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin , 10126 Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gruden","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin , 10126 Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"issue":"7006","key":"2023122122174750600_dgad468-B1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"2023122122174750600_dgad468-B2","doi-asserted-by":"crossref","first-page":"6890501","DOI":"10.1155\/2018\/6890501","article-title":"MicroRNA and microvascular complications of diabetes","volume":"2018","author":"Barutta","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"4","key":"2023122122174750600_dgad468-B3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cvr\/cvr300","article-title":"Role of microRNAs in diabetes and its cardiovascular complications","volume":"93","author":"Shantikumar","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"6","key":"2023122122174750600_dgad468-B4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"23","key":"2023122122174750600_dgad468-B5","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1074\/jbc.M110.107821","article-title":"Secretory mechanisms and intercellular transfer of microRNAs in living cells","volume":"285","author":"Kosaka","year":"2010","journal-title":"J Biol Chem"},{"issue":"4","key":"2023122122174750600_dgad468-B6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2023122122174750600_dgad468-B7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1476-4598-9-306","article-title":"Serum microRNAs as non-invasive biomarkers for cancer","volume":"9","author":"Brase","year":"2010","journal-title":"Mol Cancer"},{"issue":"1","key":"2023122122174750600_dgad468-B8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.25056","article-title":"MicroRNA as biomarkers and diagnostics","volume":"231","author":"Wang","year":"2016","journal-title":"J Cell Physiol"},{"issue":"7","key":"2023122122174750600_dgad468-B9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00592-020-01656-9","article-title":"Novel biomarkers of diabetic kidney disease: current status and potential clinical application","volume":"58","author":"Barutta","year":"2021","journal-title":"Acta Diabetol"},{"issue":"7","key":"2023122122174750600_dgad468-B10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/09537104.2020.1810223","article-title":"Contribution of platelet-derived microRNAs to serum microRNAs in healthy men","volume":"32","author":"Wakabayashi","year":"2021","journal-title":"Platelets"},{"issue":"6","key":"2023122122174750600_dgad468-B11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1161\/ATVBAHA.114.305048","article-title":"Impairment of wound healing in patients with type 2 diabetes mellitus influences circulating microRNA patterns via inflammatory cytokines","volume":"35","author":"Dangwal","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023122122174750600_dgad468-B12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fgene.2014.00099","article-title":"mir-191-5p: an emerging player in disease biology","volume":"5","author":"Nagpal","year":"2014","journal-title":"Front Genet"},{"issue":"8","key":"2023122122174750600_dgad468-B13","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1096\/fj.201601263R","article-title":"mir-191-5p suppresses angiogenesis by activation of NF-\u03baB signaling","volume":"31","author":"Gu","year":"2017","journal-title":"FASEB J"},{"key":"2023122122174750600_dgad468-B14","doi-asserted-by":"crossref","first-page":"e21184","DOI":"10.1096\/fj.202000645RR","article-title":"MicroRNA-191-5p ameliorates amyloid-\u03b21-40 -mediated retinal pigment epithelium cell injury by suppressing the NLRP3 inflammasome pathway","volume":"35","author":"Chen","year":"2021","journal-title":"FASEB J"},{"issue":"8","key":"2023122122174750600_dgad468-B15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/cells11081254","article-title":"Comprehensive characterization of platelet-enriched microRNAs as biomarkers of platelet activation","volume":"11","author":"Krammer","year":"2022","journal-title":"Cells"},{"key":"2023122122174750600_dgad468-B16","doi-asserted-by":"crossref","first-page":"418628","DOI":"10.1155\/2014\/418628","article-title":"Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction","volume":"2014","author":"Hsu","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"2023122122174750600_dgad468-B17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40001-015-0148-y","article-title":"Clinical impact of circulating miR-26a, mir-191-5p, and miR-208b in plasma of patients with acute myocardial infarction","volume":"20","author":"Li","year":"2015","journal-title":"Eur J Med Res"},{"issue":"1","key":"2023122122174750600_dgad468-B18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cjca.2020.03.018","article-title":"Circulating miRNAs related to long-term adverse cardiovascular events in STEMI patients: a nested case-control study","volume":"37","author":"Yang","year":"2021","journal-title":"Can J Cardiol"},{"key":"2023122122174750600_dgad468-B19","doi-asserted-by":"crossref","first-page":"738576","DOI":"10.3389\/fnins.2021.738576","article-title":"Dysregulation of principal circulating miRNAs in non-human primates following ischemic stroke","volume":"15","author":"Chen","year":"2021","journal-title":"Front Neurosci"},{"issue":"4","key":"2023122122174750600_dgad468-B20","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1373\/clinchem.2012.195297","article-title":"Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome","volume":"59","author":"Luo","year":"2013","journal-title":"Clin Chem"},{"issue":"6","key":"2023122122174750600_dgad468-B21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ Res"},{"issue":"5","key":"2023122122174750600_dgad468-B22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00592-014-0617-8","article-title":"Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes","volume":"51","author":"Yang","year":"2014","journal-title":"Acta Diabetol"},{"issue":"2","key":"2023122122174750600_dgad468-B23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00592-016-0915-4","article-title":"MicroRNA-126 and micro-\/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study","volume":"54","author":"Barutta","year":"2017","journal-title":"Acta Diabetol"},{"issue":"3","key":"2023122122174750600_dgad468-B24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00398055","article-title":"Microvascular and acute complications in IDDM patients: the EURODIAB IDDM complications study","volume":"37","author":"The EURODIAB IDDM Complications Study Group","year":"1994","journal-title":"Diabetologia"},{"issue":"10","key":"2023122122174750600_dgad468-B25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s00125-002-0914-6","article-title":"Trends in hypertension management in type I diabetes across Europe, 1989\/1990\u20131997\/1999","volume":"45","author":"Soedamah-Muthu","year":"2002","journal-title":"Diabetologia"},{"issue":"2","key":"2023122122174750600_dgad468-B26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2337\/diacare.24.2.284","article-title":"Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes","volume":"24","author":"Chaturvedi","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"2023122122174750600_dgad468-B27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00125-004-1628-8","article-title":"Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes: the EURODIAB prospective complications study","volume":"48","author":"Schram","year":"2005","journal-title":"Diabetologia"},{"issue":"9","key":"2023122122174750600_dgad468-B28","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2337\/dc12-0089","article-title":"NH2-terminal Probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-?","volume":"35","author":"Gruden","year":"2012","journal-title":"Diabetes Care"},{"issue":"33","key":"2023122122174750600_dgad468-B29","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"2023122122174750600_dgad468-B30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/diacare.28.6.1383","article-title":"Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB Prospective Complications Study","volume":"28","author":"van Hecke","year":"2005","journal-title":"Diabetes Care"},{"issue":"suppl_1","key":"2023122122174750600_dgad468-B31","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diacare.27.2007.S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"issue":"6","key":"2023122122174750600_dgad468-B32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"Modification ofDiet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"1","key":"2023122122174750600_dgad468-B33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00125-012-2743-6","article-title":"Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study","volume":"56","author":"Tielemans","year":"2013","journal-title":"Diabetologia"},{"issue":"2","key":"2023122122174750600_dgad468-B34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00125-004-1628-8","article-title":"EURODIAB Prospective Complications Study Group. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes: the EURODIAB prospective complications study","volume":"48","author":"Schram","year":"2005","journal-title":"Diabetologia"},{"issue":"4","key":"2023122122174750600_dgad468-B35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/CIRCRESAHA.111.300539","article-title":"Circulating microRNAs as novel biomarkers for platelet activation","volume":"112","author":"Willeit","year":"2013","journal-title":"Circ Res"},{"issue":"8","key":"2023122122174750600_dgad468-B36","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190548","article-title":"MicroRNA-191-5p diminished sepsis-induced acute kidney injury through targeting oxidative stress responsive 1 in rat models","volume":"39","author":"Qin","year":"2019","journal-title":"Biosci Rep"},{"issue":"3","key":"2023122122174750600_dgad468-B37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.yexmp.2015.10.003","article-title":"Differentially expressed microRNAs in kidney biopsies from various subtypes of nephrotic children","volume":"99","author":"Lu","year":"2015","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"2023122122174750600_dgad468-B38","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.120.16598","article-title":"Urinary- and plasma-derived exosomes reveal a distinct microRNA signature associated with albuminuria in hypertension","volume":"77","author":"Perez-Hernandez","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"2023122122174750600_dgad468-B39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ajh\/hpaa031","article-title":"Circulating let-7g-5p and mir-191-5p-5p are independent predictors of chronic kidney disease in hypertensive patients","volume":"33","author":"Berillo","year":"2020","journal-title":"Am J Hypertens"},{"issue":"23","key":"2023122122174750600_dgad468-B40","doi-asserted-by":"crossref","first-page":"22400","DOI":"10.1007\/s11356-017-0277-7","article-title":"MicroRNA-191, acting via the IRS-1\/Akt signaling pathway, is involved in the hepatic insulin resistance induced by cigarette smoke extract","volume":"25","author":"Yang","year":"2018","journal-title":"Environ Sci Pollut Res Int"},{"key":"2023122122174750600_dgad468-B41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fgene.2017.00189","article-title":"Post-transcriptional regulation of PCSK9 by mir-191-5p, miR-222, and miR-224","volume":"8","author":"Naeli","year":"2017","journal-title":"Front Genet"},{"issue":"6","key":"2023122122174750600_dgad468-B42","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11010-022-04385-5","article-title":"LncRNA XIST facilitates hypoxia-induced myocardial cell injury through targeting miR-191-5p\/TRAF3 axis","volume":"477","author":"Wang","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"2023122122174750600_dgad468-B43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2016.03.037","article-title":"MicroRNA mir-191-5p targets the zinc finger transcription factor Egr-1 and suppresses intimal thickening after carotid injury","volume":"212","author":"Yue Li","year":"2016","journal-title":"Int J Cardiol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad468\/51279638\/dgad468.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e163\/54731271\/dgad468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/1\/e163\/54731271\/dgad468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T18:59:36Z","timestamp":1729882776000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/1\/e163\/7239256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,8]]},"published-print":{"date-parts":[[2023,12,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad468","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,8,8]]}}}